Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder

NCT07226661 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

230

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder (MDD)

Interventions

DRUG: SPN-821 2400 mg
DRUG: Placebo

Sponsor

Supernus Pharmaceuticals, Inc.